US 10322099
Process to prepare treprostinil, the active ingredient in remodulin®
granted A61KA61K31/192A61P
Quick answer
US patent 10322099 (Process to prepare treprostinil, the active ingredient in remodulin®) held by United Therapeutics Corporation expires Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Jun 18 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K31/192, A61P, A61P1/00, A61P1/14